Gunst JD, Hojen JF, Pahus MH, Rosas-Umbert M, et al. Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial. Nat Med 2023 Sep 11. doi: 10.1038/s41591-023-02547.
PMID: 37696935